Display options
Share it on

Pharm Pract (Granada). 2021 Jan-Mar;19(1):2206. doi: 10.18549/PharmPract.2021.1.2206. Epub 2021 Mar 22.

Knowledge and behavior of consumers towards the non-prescription purchase of antibiotics: An insight from a qualitative study from New Delhi, India.

Pharmacy practice

Anita Kotwani, Jyoti Joshi, Anjana S Lamkang, Ayushi Sharma, Deeksha Kaloni

Affiliations

  1. PhD (Pharmacol). Professor & Head of Pharmacology Department, Vallabhbhai Patel Chest Institute (VPCI), University of Delhi. Delhi (India). [email protected].
  2. MD, MBBS (Commun Med). Adjunct Professor. Amity Institute of Public Health, Center for Disease Dynamics, Economics and Policy (CDDEP), Amity University and Head-South Asia. New Delhi (India). [email protected].
  3. PhD (Anthropol). Fellow. Center for Disease Dynamics, Economics and Policy (CDDEP). New Delhi (India). [email protected].
  4. MSc (Anthropol). Senior Research Fellow. Pharmacology Department, Vallabhbhai Patel Chest Institute (VPCI), University of Delhi. Delhi (India). [email protected].
  5. MTech. (Biotechnol). Junior Research Fellow. Pharmacology Department, Vallabhbhai Patel Chest Institute (VPCI), University of Delhi. Delhi (India). [email protected].

PMID: 33828621 PMCID: PMC8005328 DOI: 10.18549/PharmPract.2021.1.2206

Abstract

BACKGROUND: In Low-and Middle-Income Countries, including India, consumers often purchase antibiotics over-the-counter (OTC) from retail pharmacies. This practice leads to the inappropriate use of antibiotics in the community which is an important driver for the development of antimicrobial resistance. A better understanding of consumers' views towards this grave public health concern is critical to developing evidence-based intervention programs for awareness among the general population.

OBJECTIVE: To explore knowledge, practice and, behavior of consumers towards antibiotics, antibiotic use, antimicrobial resistance, purchasing behavior of consumers for antibiotics, and to gain insight which will help in developing evidence-based policy interventions.

METHODS: 72 in-depth consumer interviews were conducted in all 11 districts of the National Capital Territory of Delhi. The qualitative data were analyzed using thematic analysis.

RESULTS: Our study found that retail pharmacies were the first point of consultation for common ailments for patients/consumers once home remedies failed; they were largely unaware of the threat of antimicrobial resistance. Consumers' knowledge of antibiotic use and about antimicrobial resistance was low, they used old prescriptions, and bought antibiotics OTC to save time and money. Despite the presence of regulations constituted to regulate the sale of antibiotics by the Government and the implementation of national campaigns, the practice of self-medication and behaviors such as OTC purchase, non-adherence to prescribed antibiotics was prevalent. Consumers perceive that antibiotics provide quick relief and accelerate the curing process and retail pharmacy shops try to protect their retail business interests by honoring old prescriptions and self-medication for antibiotics.

CONCLUSIONS: The lack of awareness and insufficient knowledge about what antibiotics are and issues such as antimicrobial resistance or antibiotic resistance resulted in misuse of antibiotics by consumers. Limited access to public healthcare and affordability of private healthcare are factors that contribute towards the self-medication/OTC purchase of antibiotics. The regular misuse of antibiotics through irrational use reinforces the need for strong enactment of strategies like continuous community awareness campaigns. Mitigation efforts should focus upon educating consumers continuously and sustainably for the understanding of antibiotic misuse, antimicrobial resistance, and promote better compliance with regulations.

Copyright: © Pharmacy Practice and the Authors.

Keywords: Anti-Bacterial Agents; Bacterial; Commerce; Developing Countries; Drug Resistance; Evidence-Based Practice; India; Nonprescription Drugs; Pharmacies; Pharmacists; Prescriptions; Public Health; Qualitative Research; Self Medication

Conflict of interest statement

CONFLICT OF INTEREST The authors declare no conflict of interest.

References

  1. Pharm Pract (Granada). 2017 Jan-Mar;15(1):827 - PubMed
  2. BMJ. 2016 Feb 29;352:i1202 - PubMed
  3. Health Policy. 2006 Jul;77(2):166-71 - PubMed
  4. Lancet Glob Health. 2017 Nov;5(11):e1075-e1076 - PubMed
  5. BMJ. 2012 Apr 03;344:e1567 - PubMed
  6. PLoS One. 2019 Feb 28;14(2):e0212875 - PubMed
  7. Lancet Infect Dis. 2014 Aug;14(8):742-750 - PubMed
  8. Infect Drug Resist. 2009;2:1-11 - PubMed
  9. BMC Public Health. 2019 Oct 15;19(1):1292 - PubMed
  10. J Clin Pharm Ther. 2012 Jun;37(3):308-12 - PubMed
  11. Lancet Infect Dis. 2013 Dec;13(12):1057-98 - PubMed
  12. Risk Manag Healthc Policy. 2014 Feb 20;7:35-44 - PubMed
  13. BMC Infect Dis. 2011 Apr 20;11:99 - PubMed
  14. PLoS One. 2013 Dec 23;8(12):e84177 - PubMed
  15. Pharm Pract (Granada). 2018 Apr-Jun;16(2):1172 - PubMed
  16. Health Policy Plan. 2016 Mar 8;31(7):940-953 - PubMed
  17. BMC Public Health. 2017 Oct 10;17(1):799 - PubMed
  18. Antibiotics (Basel). 2017 Oct 31;6(4): - PubMed
  19. Health Aff (Millwood). 2012 Dec;31(12):2774-84 - PubMed
  20. Int J Qual Health Care. 2007 Dec;19(6):349-57 - PubMed
  21. Health Expect. 2014 Oct;17(5):651-63 - PubMed
  22. Patient Educ Couns. 2008 Oct;73(1):146-52 - PubMed
  23. Trop Med Int Health. 2014 Jul;19(7):761-8 - PubMed
  24. BMC Public Health. 2017 Apr 19;17(1):333 - PubMed
  25. Lancet. 2011 Jan 15;377(9761):228-41 - PubMed
  26. PLoS Med. 2009 Jun 2;6(6):e1000084 - PubMed
  27. Int J Antimicrob Agents. 2018 Dec;52(6):771-782 - PubMed
  28. BMJ Open. 2017 Mar 2;7(3):e013190 - PubMed
  29. PLoS One. 2020 Jan 16;15(1):e0227973 - PubMed
  30. BMJ. 2010 May 18;340:c2096 - PubMed
  31. Ups J Med Sci. 2014 May;119(2):125-33 - PubMed
  32. BMJ. 2015 Sep 30;351:h5195 - PubMed
  33. Indian J Pharmacol. 2016 Jul-Aug;48(4):365-371 - PubMed
  34. Pharm Pract (Granada). 2019 Jul-Sep;17(3):1540 - PubMed
  35. Indian J Pharmacol. 2017 Nov-Dec;49(6):419-431 - PubMed
  36. PLoS One. 2019 Jun 27;14(6):e0219002 - PubMed
  37. Emerg Infect Dis. 2006 Mar;12(3):452-9 - PubMed
  38. PLoS One. 2012;7(7):e41314 - PubMed

Publication Types